S

Shanghai Wanye Enterprises Co Ltd
SSE:600641

Watchlist Manager
Shanghai Wanye Enterprises Co Ltd
SSE:600641
Watchlist
Price: 18.95 CNY 5.81% Market Closed
Market Cap: ¥17.3B

Gross Margin

26.2%
Current
Declining
by 13.4%
vs 3-y average of 39.6%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
26.2%
=
Gross Profit
¥352.2m
/
Revenue
¥1.3B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
26.2%
=
Gross Profit
¥352.2m
/
Revenue
¥1.3B

Market Distribution

In line with most companies in China
Percentile
56th
Based on 8 314 companies
56th percentile
26.2%
Low
-2 148% — 14.3%
Typical Range
14.3% — 34.6%
High
34.6% — 775.2%
Distribution Statistics
China
Min -2 148%
30th Percentile 14.3%
Median 23%
70th Percentile 34.6%
Max 775.2%

Shanghai Wanye Enterprises Co Ltd
Glance View

Market Cap
17.3B CNY
Industry
Real Estate

Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.

Intrinsic Value
5.73 CNY
Overvaluation 70%
Intrinsic Value
Price
S
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
26.2%
=
Gross Profit
¥352.2m
/
Revenue
¥1.3B
What is Shanghai Wanye Enterprises Co Ltd's current Gross Margin?

The current Gross Margin for Shanghai Wanye Enterprises Co Ltd is 26.2%, which is below its 3-year median of 39.6%.

How has Gross Margin changed over time?

Over the last 3 years, Shanghai Wanye Enterprises Co Ltd’s Gross Margin has decreased from 48.7% to 26.2%. During this period, it reached a low of 26.2% on Oct 30, 2025 and a high of 48.7% on Aug 30, 2022.

Back to Top